- Home
- KUST vs PPCB Comparison
KUST vs PPCB Comparison
Compare KUST & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KUST | PPCB |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4M | 2.6M |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | KUST | PPCB |
|---|---|---|
| Price | $3.67 | $0.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 16.9K | ★ 213.1K |
| Earning Date | 11-11-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,577,600.00 | N/A |
| Revenue This Year | $40.06 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.55 | $0.06 |
| 52 Week High | $224.00 | $6.79 |
Technical Indicators
Market Signals| Indicator | KUST | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 44.41 | 25.33 |
| Support Level | N/A | $0.17 |
| Resistance Level | $17.87 | $0.40 |
| Average True Range (ATR) | 1.24 | 0.05 |
| MACD | -0.87 | 0.00 |
| Stochastic Oscillator | 0.17 | 2.01 |
Price Performance
Historical ComparisonAbout KUST Kustom Entertainment Inc. Common Stock
Kustom Entertainment Inc provides live event production and ticketing technology services. The company operates in two segments: video solutions and entertainment. The Video Solutions Segment represents the Company's legacy operations and includes the development, manufacture, and sale of digital video imaging and storage products, disinfectant, and related safety products for use in law enforcement, security, and commercial applications. The Entertainment Segment operates a secondary ticketing platform through TicketSmarter.com, acting as an intermediary between ticket buyers and sellers. In addition, this segment includes live event production and promotion activities, including the Country Stampede music festival and other entertainment events.
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.